Kaplan-Meier survival analysis demonstrated that patients with high expression of either MOAP-1 or RASSF1A experienced greater survival rates versus those with low expression of either gene (Fig. 1, B and C), thereby suggesting that both MOAP-1 and RASSF1A may behave as tumor suppressor proteins in the pathogenesis of neuroblastoma. The gene discussed is MOAP1; the disease is neuroblastoma.